Neuralink Impact on Dreams and Meditation: Dream Analysis
- Neuralink's current implant records from the motor cortex, the part of the brain that plans movement, and has not been used to study dreams or meditation.
- Recording dreams or guiding meditation would require access to other brain regions and research that has not been done.
- This article is speculation about possible future uses, with the facts about today's device marked as such.
What today's implant can record
Neuralink's N1 implant records spikes from 1,024 electrodes in the motor cortex. Participants use it to move cursors, type, and control robotic arms. The threads reach only a few millimeters into the outer layer of the brain, so the implant cannot record from deep structures such as the hippocampus, which is involved in memory and in the replay of experiences during sleep, as Neuralink's technology page describes.
Neuralink has not published any data on how its implant behaves during sleep, and it has not tested the device for dreams or meditation.
Sleep and pain
Elon Musk wrote in October 2024 that Neuralink should prioritize an implant that can eliminate back and neck pain, which he said would improve sleep. That would be a different device from the one in today's trials, aimed at pain signals rather than movement.
Dreams and lucid dreaming
Lucid dreaming, in which a sleeper knows they are dreaming and can steer the dream, has been linked to activity in the front of the brain during REM sleep. In principle, an implant that both records and stimulates could one day detect REM sleep and try to prompt lucidity. No Neuralink device has been designed or tested for that, and no data exists on how well it would work.
Meditation
Meditation research often uses EEG, sensors on the scalp that measure broad rhythms such as alpha and theta waves. A brain implant records individual neurons in one small area, which is a different kind of signal. Any use of Neuralink for meditation feedback would need new research to show that it helps.
Altered states
Some researchers study psychedelics and deep brain stimulation as treatments for depression. Neuralink has not announced work in this area, and its trials focus on paralysis, speech loss, and, in the future, blindness.
What the trials show today
Participants have streamed over 50,000 hours of neural data, according to Neuralink (October 2026), and Neuralink reported zero serious device-related adverse events as of January 2026. Neuralink's roadmap targets 25,000 channels by 2028, which would give future implants far more data, but uses beyond medicine remain untested.
This article was first published in October 2025 and corrected in October 2026; the latest patient count is on the patient table.
